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Abstract
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Periodontal diseases are a major public health concern leading to tooth loss and also shown to be
associated with several chronic systemic diseases. Smoking is a major risk factor for developing
numerous systemic diseases, as well as periodontitis. While it is clear that smokers have a
significantly enhanced risk for developing periodontitis leading to tooth loss, the population varies
with regards to susceptibility to disease associated with smoking. This investigation focuses on
identifying differences in four broad sets of variables consisting of: (a) host response molecules,
(b) periodontal clinical parameters, (c) antibody measures for periodontal pathogens and oral
commensal bacteria challenge, and (d) other variables of interest in a smoking population with (n
= 171) and without periodontitis (n = 117). Subsequently, Bayesian network structured learning
techniques (BNSL) techniques were used to investigate potential associations and cross-talk
between the four broad sets of variables. BNSL revealed two broad communities with markedly
different topology between the non-periodontitis and periodontitis smoking population.
Confidence of the edges in the resulting network also showed marked variations within and
between the periodontitis and non-periodontitis groups. The results presented validated known
associations, as well as discovered new ones with minimal precedence that may warrant further
investigation and novel hypothesis generation. Cross-talk between the clinical variables and
antibody profiles of bacteria were especially pronounced in the case of periodontitis and mediated
by the antibody response profile to P. gingivalis.
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Periodontal diseases are a major public health concern leading to tooth loss and associated
chronic systemic diseases (1–7). Bacterial-induced periodontal diseases have been
categorized into two general types related to connective tissue attachment loss and alveolar
bone resorption, ie. gingivitis and periodontitis. Gingivitis is a reversible inflammation of the
gum tissue (i.e., gingiva) caused by the presence of a biofilm that forms on the tooth surface
and resolves rather quickly after the reinstitution of mechanical and chemical oral hygiene
procedures. Most individuals will experience at least mild and transient gingivitis at some
time in their life (8–10). Periodontitis characterized by persistent gingival inflammation,
breakdown of the connective tissue (i.e., attachment apparatus surrounding teeth), and
destruction of alveolar bone (11, 12) with epidemiologic data supporting the concept of
differential susceptibility to periodontitis regarding onset, rate of progression, and severity
across the population (13, 14).
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Smoking is a major risk factor for developing numerous systemic diseases, as well as
periodontitis (15–18). Smokers frequently present with lower levels of gingival bleeding
than would be predicted based upon the level of tissue destruction of the periodontium (19)
This is likely due to effects of the smoke derived xenobiotics on local vascular functions (19,
20), while tobacco smoke appears to amplify the inflammatory response to the microbial
challenge (21–23). A report using NHANES III data determined that a population
attributable risk (PAR) for current or former smoking was approximately 50% for exhibiting
periodontitis (24). However, while it is clear that smokers have a significantly enhanced risk
for developing periodontitis leading to tooth loss, the population varies with regards to
susceptibility to disease associated with smoking (25, 26).
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The oral ecology in an individual evolves over time with variations in quantity and quality of
phyla, genera and species (27), as well as the genomic profile of the individual species (28–
30). However, this evolution generally leads to an equilibrium between the microbiota and
the individual’s oral environment, as a climax community. The resulting microbial
communities or biofilms are complex ecosystems of bacteria that are somewhat unique to
various ecological niches in the oral cavity (31). The microbiomes of the subgingival
environment of periodontally healthy and periodontally diseased sites are quite distinct (27,
32). The accretion of tooth-associated bacterial biofilms elicits gingival inflammation as a
result of bacterial virulence and metabolic factors affecting tissue vasculature. In sites
colonized by more pathogenic biofilms, the inflammatory response results in destruction of
connective tissue and alveolar bone, the classic features of periodontitis. Various extrinsic
environmental factors can also affect the microbial composition in the oral cavity, as well as
host response patterns. Recent studies have demonstrated clear effects of smoking on the
composition of the microbiome at sites of periodontitis and peri-implantitis (33–36).
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The accumulation of these biofilms also elicits a robust inflammatory response with the
cellular infiltrate releasing a panoply of pro-inflammatory molecules that initiate clinical
inflammatory measures of gingival redness and edema (14, 37, 38). Numerous studies of
gingival crevicular fluid at inflamed sites have identified associated biomolecules, such as
IL-1β, PGE2, IL-10, and acute phase response proteins, including plasminogen activator
inhibitor-1 (PAI-1) and myeloperoxidase (MPO), which can contribute to local antibacterial
responses (39). The current paradigm in periodontal disease is a local chronic infection with
microbial dysbiosis (40) that triggers a persistent destructive inflammatory response, rather
than direct toxic/noxious actions of the bacterial virulence factors (41). Beyond innate
immune and inflammatory responses, substantial literature documents the production of
specific local and systemic antibodies to oral bacteria (38). Bacterial species-specific
antibody levels increase significantly with periodontitis and decrease following therapy (14,
38). Additionally, various studies have demonstrated alterations in the characteristics of the
induced antibody in the presence of smoking (42–44). However, there is rather limited data
regarding these adaptive immune responses in smokers presenting with a range of
periodontal health and periodontal diseases.
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The present study investigates changes in magnitude of four broad sets of variables
consisting of: (a) host response molecules, (b) periodontal clinical parameters, (c) antibody
measures of periodontal pathogens and oral commensal bacteria and (d) other variables of
interest related to smoking population with (n = 171) and without periodontitis (n = 117).
Subsequently, it investigates the potential associations and cross-talk between these variables
using Bayesian network structured learning techniques (BNSL). BNSL is a probabilistic
approach and widely used (45–47) to model direct as well as conditional dependencies
between a given set of variables. In contrast to traditional statistical modeling, BNSL does
not impose a pre-defined relationship between the given set of variables. It rather aims to
discover these relationships from the data generated across the variables and abstract them as
directed acyclic graphs (DAGs). The resulting DAGs can validate established associations as
well as discover novel undocumented associations providing a more informed basis for
hypothesis generation in addition to hypothesis testing. More importantly, a break down in
associations across disease states is accompanied by marked changes in the topology or
wiring pattern (48–50) of the DAGs as shown in this study. DAGs also serve as useful
system-level abstractions of the concerted working of the variables that may not be readily
apparent by investigating the variables in isolation. While BNSL has the potential to reveal
causal relationships there are definite limitations to this approach. The DAG representation
of the relationships between the variables in BNSL implicitly assumes absence of feedback
between them. Such an assumption need not necessarily be true in general. Also, the number
of potential structures in BNSL increases markedly with the number of variables
discouraging an exhaustive search for all potential structures especially when the number of
variables is large. PDAGs returned by BNSL essentially represents multiple structures that
are probabilistically equivalent (equivalence class) as opposed to a single structure and may
result in graphs comprising of directed as well as undirected edges. Thus BNSL can learn
the associations between the variables only up to the equivalence class irrespective of the
choice of the sample size. While directed edges may indicate potential causal relationships,
undirected edges provide no such insights. However, it is important to note that causal
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associations can be determined ideally only through active interventions. Thus associations
returned by BNSL need to be validated experimentally using appropriate interventions.

MATERIALS and METHODS
Patient Population and Clinical Parameters
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The cohort included 30 periodontally healthy subjects (M:F – 7:23), 55 gingivitis patients
(M:F – 14:41), and 184 periodontitis patients (M:F – 73:111) ages 21–65 years. The
protocol for this study was approved by the University of Kentucky Institutional Review
Board and all participants signed an appropriate consent form. A comprehensive oral and
periodontal examination was completed to assess the periodontal health. Inclusion/exclusion
criteria for participating in the study: must be smokers, able to complete a questionnaire and
sign a consent form, have a minimum of 20 teeth, willing to have blood drawn, whole saliva
collected, and have a full periodontal evaluation.
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Three clinical parameters routinely used for periodontal evaluation: (a) mean probing pocket
depth (PPD), (b) clinical attachment level (51), and (c) bleeding on probing (BOP) were
obtained from all patients. Full-mouth mean pocket depth and attachment level measured in
millimeters (mm), and bleeding on probing, measured by percentage of sites in the mouth
that bleed were determined at 6 sites per tooth excluding third molars (52). The
measurements were taken and recorded by a single examiner. Measures of BOP and PPD
were used to categorize the patients recognizing that various patients fell into “gray” areas.
These “gray” area patients were assigned to a category and simply contributed to the
variation within the different groups. We used a mean PPD ≤2.5 mm for non-periodontitis
(ie. Health and Gingivitis) and ≥2.5 mm for periodontitis. While all Gingivitis subjects were
categorized accurately (>20% sites BOP; mean PPD ≤2.5 mm), a subset of healthy subjects
(26) had mean PD ≥2.5 mm, but limited % BOP and no sites with >4 mm pocket depths.
Two of the periodontitis subjects had mean PPD ≤2.5 mm, but these subjects also had high
% BOP and numerous sites with >4 mm pocket depths.
Variables such as age (Age), pack years of smoking (Yrs), salivary cotinine (Cot) levels, and
body mass index (BMI) that have been traditionally investigated in periodontitis and
smoking population studies were also included in the analysis.
Serum Analyses
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Serum from a venipuncture blood sample was originally obtained from a group of 301
smokers (age 21–65, 82 black, 219 white; 106 males, 195 females). After preliminary
investigation and eliminating missing values the subjects were distributed to nonperiodontitis (NP; n=117) and periodontitis (PD; n=171) groups. The serum samples were
stored at −80°C until the assays were performed. An array of oral microorganisms were used
in the assays, cultivated under standard conditions, and prepared for antigens as described
previously (53). The bacteria included periodontal pathogens: Aggregatibacter
actinomycetemcomitans (Aa) strain JP2, Porphyromonas gingivalis (Pg) ATCC 33277,
Treponema denticola (Td) ATCC 35405, and a group of oral commensal bacteria that
included Streptococcus sanguinis (Ss) ATCC 10556, Actinomyces naeslundii (An) ATCC
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49340, Veillonella parvula (Vp) ATCC 10790, Capnocytophaga ochracea (Co) ATCC 33596.
An ELISA was used to determine the level of IgG antibody to the bacteria (52). Purified
human IgG was bound to the plate to produce a standard curve. Sample data was
extrapolated from this curve, using a four parameter logistic curve fit (54).
Molecular markers of inflammatory responses in serum, including interleukin-1β (IL-1β),
plasminogen activator inhibitor-1 (PAI-1), myeloperoxidase (MPO), and IL-10 were
evaluated using Luminex beadlyte technology (EMD Millipore, Billerica, MA) or
commercial high sensitivity PGE2 ELISA ELISA kits (Assay Design, Ann Arbor, MI) (42).
Salivary cotinine levels were measured in whole saliva using an ELISA (Salimetrics’ High
Sensitivity Salivary Cotinine Quantitative enzyme immunoassay kit, Carlsbad, CA) as we
have described previously (43).
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Statistical Analyses

Author Manuscript

Parametric t-test was used to identify those variables whose magnitude changed significantly
across non-periodontitis and periodontitis groups after controlling the false-discovery rate
(55). Variables whose adjusted p-values were significant (p < 0.02) are reported.
Subsequently, BNSL was used to model potential associations between 15 variables
comprising critical proteins (IL-1β, PAI-1), clinical parameters (BOP, PD, CAL), antibody
to periodontal pathogens (Aa, Pg, Td) and oral commensal bacteria (Co, An, Vp, Ss), and
other variables (Age, Yrs, Cot) across periodontitis and non-periodontitis subjects in the
smoking population. Several techniques, such as constraint-based and search-score
approaches, have been traditionally proposed in the literature for BNSL (56–58). Recent
studies have shown that hybrid techniques such as max-min hill climbing (MMHC) that use
a combination of constraint-based and search-score frameworks in tandem to outperform
either of these approaches (59). Constraint-based part of MMHC uses max-min parentschildren approach to determine the skeleton of the underlying network. Subsequently, a
Bayesian-greedy hill-climbing approach is used to determine the orientation of the edges in
the skeleton. Partially directed acyclic graph (PDAG) representations that incorporate
equivalence classes of the DAGs were subsequently generated (56, 57) in order to account
for DAGs are probabilistically indistinguishable. Confidence of the edges (60, 61) in the
PDAGs was determined from 1000 independently by resampling with replacement and
edges with confidence less than 30% were deemed noisy, hence eliminated from further
consideration. The remaining edges along with their confidences are reported as weighted
graphs. Open-source implementation of the MMHC approach as a part of the bnlearn R
package (62, 63) was used in the present study. Graphical layouts were generated using
Gephi (64).
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RESULTS
Adjusted p-values (p < 0.02) from a parametric t-test after controlling the false-discovery
rate (55) revealed eight variables to exhibit a marked difference between the periodontitis
(PD) and non-periodontitis (NP) groups (Table 1). As expected, the three clinical parameters
(BOP, PPD, CAL) were significantly elevated in the periodontitis group as opposed to the
NP group. As the groups were defined by clinical parameters, it was expected that these
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would be significantly different. Of the remaining variables, IL-1β, PAI-1, pack-years of
smoking, and antibody to P. gingivalis and A. naeslundii were also significantly elevated in
the periodontitis group. Since previous results had not evaluated variations in host responses
across clinical presentation in smokers, alterations in targeted inflammatory mediators and
antibody levels, particularly to P. gingivalis, were undefined previously, but not totally
unexpected.
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Subsequently, Max-Min hill climbing approach was used to generate the Bayesian networks
representing the interplay between 15 clinical and host response variables across the NP and
PD smoking population. Confidence of the edges in the network was generated across 1000
independent bootstrap realizations. The five sets of variables are shown by distinct colors in
Figs.1a–1b for clarity and the thickness of the edges is proportional to their confidence
represented in these figures. Edges whose confidences were <30% were deemed noisy,
hence not reported. The networks corresponding to NP and PD exhibit two broad
communities revealing intricate associations and cross-talk between (clinical parameters,
other variables, Community 1) and (antibacterial responses, Community 2). However, there
were substantial differences in the wiring pattern between them. Confidence of the edges
showed marked variations within and between the NP and PD groups. While the network
corresponding to NP is disconnected (Fig. 1a) that of the periodontitis patients is weakly
connected (i.e. it is possible to traverse between any two variables in the underlying
undirected graph) (Fig. 1b).
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More importantly, in the case of periodontitis, antibody to P. gingivalis seems to act as a
mediator establishing an association between otherwise unrelated variables (eg. CAL and
Aa) and in turn establishing potential associations between the parameters of Community 1
and 2. Unlike the PD group, there were no apparent relationships between BOP and mean
pocket depth (PPD) in the case of the NP group. Scatter plots of (%BOP vs. PPD) also
validated these findings with the absence of a significant direct association in the NP group
(r=−0.15) as opposed to the PD group (r=0.58, p<0.01) (Fig. 2a). Our analysis also revealed
some of the associations to be preserved across the NP and periodontitis groups. This
includes the correlation between antibody to the pathogen (Aa) and commensal bacterium
(Co) being reflected by prominent edges in Figs. 1a–1b. Aa and Co also exhibited a
significant direct association across NP (r=0.58, p<0.01) as well as the PD (r=0.49, p<0.01)
group (Fig. 2a). Associations between (Co and Td) were significant across NP (r=0.67,
p<0.01) and PD (r=0.61, p<0.01) groups. Associations between (Co and Pg) were also
significant across NP (r=0.63, p<0.01) and PD (r=0.39, p<0.01) groups (Fig. 2b).
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Examining the associations of systemic inflammatory mediators to the clinical parameters in
the population of smokers also provided an interesting profile. While numerous
inflammatory biomarkers have been identified in serum and related to the extent and severity
of periodontitis (23, 38, 65), the findings of this study in smokers provide a somewhat
different outcome. Confidence of the edges corresponding to (IL-1β, PAI-1) was markedly
higher in the periodontitis group as opposed to the non-periodontitis group, reflected by the
discrepancy in the thickness of the edges in Fig. 1a–1b. This was also reflected by the
marked decrease in the magnitude of the Pearson correlation between (IL–1β, PAI-1) from
the PD group (r=0.34, p<0.01) compared to the NP group (r=0.20, p=0.03). Also, IL-1β was
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associated with the clinical parameter (mean CAL) in the case of NP (Fig. 1a), whereas it
was connected to the host response variables through linkage with antibody to the pathogen
(T. denticola) in the case of PD (Fig. 1b). Also, the markers (IL-1β, PAI-1) did not exhibit a
direct association to clinical disease parameters or smoking measures in the PD group.
These results suggest that smoking may disrupt control of local and systemic inflammatory
responses that occur related to the health of the periodontium. Active smoking (i.e. salivary
cotinine levels) exhibited a strong association with the clinical parameter (CAL, p<0.01) in
the NP group (Fig. 1a), unlike that of the PD group. While obesity has been reported to be
linked to expression of periodontitis in humans (66–70), our data from a population of
individuals who were all smokers showed that BMI did not exhibit a significant association
to any of the clinical parameters, inflammatory responses, or specific antibody in either PD
or NP individuals, hence not included in Figs. 1a–1b. These observations may indicate that
certain biologic effects of smoking could overwhelm any contribution that modifiers elicited
by overweight/obesity might have in altering the presentation of this oral disease. MPO and
PGE2 exhibited a significant association across NP (r=0.50, p<0.01) and the PD (r=0.37,
p<0.01) groups solely based on the correlation coefficients and associated p-values.
However, as can be seen with the scatter plots (Fig. 3) the relationship is highly noisy,
suggesting that the correlations may primarily reflect outlier values of a few subjects in the
groups and hence are not identified as important contributors to the community relationships
identified in Fig. 1a–1b. Additional variables demonstrated minimal or no relationship to
these community linkages and are also not presented in the figure.

DISCUSSION
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Smoking is one of, if not the major cause, of preventable morbidity and mortality in the
population with substantial negative effects on general and oral health (16–18, 71). Smoking
has been clearly delineated as a major modifiable environmental risk factor in the extent/
severity of periodontal disease through cross-sectional and longitudinal epidemiologic
investigations (72). These data indicate that there is a 300–600% increase in periodontitis in
smokers compared with non-smokers (73), and there clearly is a deleterious impact of the
wide array of xenobiotics derived from smoking on the response to periodontal therapy (16,
74). Nevertheless, while a significantly enhanced proportion of smokers exhibit periodontitis
compared to the non-smoking population, clinical evaluation of smoking and periodontitis
demonstrate a proportion of the smoking population remain periodontally healthy or only
develop gingivitis (75). Another facet of the broader literature was that a subset of smokers
appeared periodontally healthy even with long term smoking (ie. pack years) and substantial
continine levels. Thus, some features of either the microbial challenge or characteristics of
the host response profile appear to afford these patients an enhanced capacity to retain tissue
homeostasis in the oral cavity. Similar observations have been summarized in a recent report
by Genco and Borgnakke (69).
We have previously demonstrated serum antibody levels to selected oral pathogens and
commensal bacteria related to race/ethnicity, age, and periodontal disease extent in a
population of smokers (43), as well as systemic inflammatory responses related to smoking
level (42). This study extended these findings by examining both serum antibodies and
inflammatory molecules related to smoking parameters, and periodontal condition to
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identify the impact of active smoking on the relationships among these various parameters.
Serum levels of IL-1β were significantly elevated in the periodontitis patients. IL-1β has
been identified to be a crucial molecule in chronic inflammatory responses, both locally and
systemically (76). (77) (78). This pro-inflammatory mediator and bone resorbing cytokine
does appear to contribute to the expression of periodontitis and has been linked to serum
levels of C-reactive protein and altered IL-6 production appearing to play a role in
periodontitis in type 2 diabetes mellitus (79). Our findings in smokers with periodontitis
with the highest cotinine levels demonstrating elevated serum IL-1β provides additional data
regarding the importance of this pro-inflammatory mediator in periodontitis.
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A number of pro-inflammatory mediators are derived via the arachidonic acid pathway,
including PGE2 (80), which has been implicated in the pathogenesis of gingival
inflammation and periodontitis (81, 82). Additional biomarkers of inflammatory responses
in the systemic circulation are components of the acute phase response, eg. PAI-1 (39). This
array of molecules serves a range of functions with the goal of reestablishing systemic
homeostasis following noxious challenge and have been related to periodontitis, periodontal
therapy, and other chronic inflammatory diseases (83, 84) (85, 86) (87, 88) (83, 84). (89)
(90), (91). Also, during the chronic inflammatory response reactive oxygen species (ROS)
and free radicals (e.g., NO and NO2) are generated by neutrophils and macrophages, often
through the action of myeloperoxidase (MPO) that is released into extracellular fluid at sites
of inflammatory lesions (92, 93) and is affected by smoking (94) (95). Alterations in MPO
have been identified to vary in periodontitis patients with/without treatment (86, 96, 97) (98)
(86, 99).
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Serum IgG antibody levels to a group of putative periodontal pathogens and oral commensal
bacteria were also evaluated. As would be expected antibody to the periodontal pathogens
were significantly elevated in the periodontitis smokers and significantly decreased in the
periodontally healthy smokers. Substantial literature has demonstrated local and systemic
adaptive immune responses to oral bacteria related to the presence, extent/severity, and
therapeutic outcomes of periodontitis (38) (44) (51). We have found similar types of
response differences in smokers related to the oral health of the individual; however, we
extended the available literature by demonstrating a racial/ethnic contribution to these
responses, as well as a difference in response profile to pathogenic compared to commensal
oral bacteria (43). As importantly, the level of serum antibody to the oral bacteria has been
shown to provide some reflection of the presence and burden of the particular
microorganism within the oral cavity (100, 101). Thus, this measure is somewhat of a
surrogate for the oral colonization, and could be suggested to reflect a challenge that the host
sees as potentially deleterious and needs to be managed (100, 101). In this regard, the
identification of antibody to A. actinomycetemcomitans interfacing with responses to P.
gingivalis and T. denticola in the non-periodontitis smokers and also linked with clinical
parameters in the periodontitis subset. Historically, periodontitis have been categorized as
chronic adult and aggressive (102) and linked to microbiological characteristics with P.
gingivalis and A. actinomycetemcomitans generally considered as representative of the
major pathogens in these diseases (103) (38, 104). The majority of these studies intermixed
both smokers and nonsmokers into their cohorts, and did often identify various clinical and
biological differences related to smoking. However, our population comprised entirely of
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smokers presented a somewhat unique profile. In the non-periodontitis (NP) group antibody
levels to P. gingivalis and A. actinomycetemcomitans were associated with antibody to an
important commensal species, C. ochracea, albeit, the level of antibody to these bacteria
were significantly lower than in the periodontitis group, as was expected (38, 43).
Interestingly, in the periodontitis patients antibody to C. ochracea, generally reflecting
microbial challenge was associated with the group of commensal bacteria and provided a
strong link to responses to the oral pathogens, ie. Aa, Pg, Td. This host response identifying
these members of the microbial ecology was also uniquely related to the clinical and
smoking community variables via responses to P. gingivalis. Thus, in the periodontitis
patients, where P. gingivalis represents a hallmark bacteria and has been proposed as a
keystone pathogen, the relationships in this smoking population reflected the capacity of P.
gingivalis to interface clinical disease with a range of host responses.
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These differences in responses were also obvious in demonstrating significant correlations of
serum PGE2, IL-1β, and PAI-1 with various smoking parameters. In contrast, the serum
antibodies lacked this type of relationship. We subsequently examined the direct relationship
between the individual serum inflammatory mediators and the adaptive immune responses in
subsets of patients stratified by salivary cotinine levels. The results demonstrated that in the
subsets with lower cotinine levels, antibodies to a number of the commensal bacteria were
significantly negatively correlated with serum PGE2 and MPO levels. In contrast, in the high
cotinine group, antibody levels to the pathogens, and particularly P. gingivalis were
significantly positively correlated with some of the inflammatory mediators (42). Thus,
while antibodies were not directly correlated with cotinine and smoking levels, there
appeared to be some interface between the systemic inflammatory and adaptive responses
related to the interactions of smoking and periodontal disease.
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The present study investigated variations in the magnitude of expression of four broad
categories of variables between periodontitis and non-periodontitis smoking population.
Subsequently, potential cross-talk and associations between these variables were investigated
using a BNSL. In contrast to traditional statistical modeling BNSL does not impose any
constraint on the associations between the variables rather discovers direct as well as indirect
associations from the given data. This aspect of BNSL is especially useful in hypothesis
generation. BNSL accommodates all the variables simultaneously and has the ability to
provide system-level insights and potential cross-talk between them, thus, BNSL is
markedly different from traditional reductionist approaches that investigate only subsets of
variables in isolation. More importantly, BNSL has the ability to validate established
associations, such as P. gingivalis responses in periodontitis and the relationship of age and
amount of smoking to clinical measure of periodontal disease. Additionally, this approach
can help to ascertain novel associations with minimal precedence, such as the relationship of
select inflammatory mediators with clinical presentation on non-periodontitis smokers,
inflammatory mediators linked more strongly to the microbial challenge in periodontitis, the
centrality of the response to C. ochracea with response profiles to both commensals and
pathogens, and the apparent ability of P. gingivalis to provide a bridge in linking bacterial
responses to clinical parameters of disease in the periodontitis subset of smokers. More
importantly, the results revealed marked variation in associations, their confidence as well as
the overall network topology between the periodontitis and non-periodontitis groups.
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Whether there are molecules in the xenobiotic mix of smoking products that trigger unique
host response profiles, or this relationship reflects a general noxious challenge to host tissues
and cells that results in some specificity for eliciting the inflammatory and adaptive
responses remains to be determined. Thus, while periodontitis is considered to reflect a
dysregulated host response to subgingival biofilms, these data suggest that smoking has the
capacity to disrupt these responses to an even greater degree, thus increasing the risk for
disease initiation/progression.
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Figure 1.

Bayesian network representing potential associations between four broad sets of variables
consisting of: (i) host response molecules (IL1β, PAI-1), (ii) periodontal clinical parameters
(PD, BOP, CAL), (iii) antibody measures of periodontal pathogens (Aa, Pg, Td) and oral
commensal bacteria (Co, Vp, An, Ss) and other variables (Age, Yrs, Cot) of interest in the
non-periodontitis and the periodontitis smoking population is shown in (a) and (b)
respectively. The four broad sets of variables are shown by different colors for clarity with
the dotted lines representing the two broad communities in (a) and (b). The thickness of the
edges in (a) and (b) are directly proportional to the edge confidence estimated from (N =
1000) bootstrap realizations.
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Figure 2.

Author Manuscript

(a) Scatter plot representing direct association between clinical parameters (Mean BOP) and
(Mean PPD) was significant in the periodontitis (red, p<0.01) as opposed to the nonperiodontitis (blue) smoking population. Association between antibody to a periodontal
pathogen (Aa) and a commensal bacteria (Co) was significant in periodontitis (red, p<0.01),
as well as the non-periodontitis (blue, p<0.01) smoking population. (b) Scatter plot
representing direct association between antibody to a periodontal pathogens (Td and Pg) and
a commensal bacteria (Co) was significant in periodontitis (red, p<0.01), as well as the nonperiodontitis (blue, p<0.01) smoking population.
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Figure 3.

Scatter plot representing potential association between serum levels of MPO and PGE2 for
the non-periodontitis and periodontitis smoking population. The correlation is rendered
significant (p < 0.01) by a few outliers in each of the case.
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Average values and standard deviations of the 18 variables across between periodontitis and non-periodontitis
smoking subjects.
Variable

Non-Periodontitis

Periodontitis

Age (years)

36.9±11.1

39.9±9.5

BMI

27.3±5.9

28.7±7.2

BOP** (% >0)

4.7±4.8

25.8±22

PPD** (mouth mean mm)

2.4±0.30

3.4±0.69

CAL** (mouth mean mm)

2.6±0.51

3.8±1

17.2±10

20.7±9.5

529.2±456.5

649.6±616.4

IL-1β** (pg/mL)

39.1±56.7

79.6±99.8

PAI-1** (ng/mL)

110.7±139.3

160.4±157.5

MPO (ng/mL)

13056.5±7316.8

15238±9316.8

PGE2 (ng/mL)

531.5±818.6

472.9±709.8

Clinical/Demographic

Smoking
Pack/years**

Author Manuscript

Salivary cotinine (ng/mL)
Inflammatory Mediators

Serum Antibody (ng/mL)

Author Manuscript

A. actinomycetemcomitans

15.3±12.9

18±13.6

A. naeslundii**

15.8±9.8

19.1±10.2

C. ochracia

10.2±5.6

11.7±7.3

29±22

42.1±32

S. sanguinis

39.5±19.3

38.1±16.2

T. denticola

14.4±10.6

17.2±12.4

V. parvula

21.8±14.7

22±12.4

P. gingivalis**

**

adjusted p-value < 0.02
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